Citadel Advisors - VINCERX PHARMA INC ownership

VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 36 filers reported holding VINCERX PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q3 2023$173,893
-79.7%
168,829
-74.4%
0.00%
Q2 2023$858,679
+32.3%
660,522
+5.9%
0.00%
Q1 2023$648,884
+2.0%
623,9270.0%0.00%
Q4 2022$636,406
-26.3%
623,927
-0.3%
0.00%
Q3 2022$863,000
+4.7%
625,560
+0.3%
0.00%
Q2 2022$824,000
-67.0%
623,927
-0.1%
0.00%
-100.0%
Q1 2022$2,498,000
-60.8%
624,378
-0.1%
0.00%0.0%
Q4 2021$6,366,000
-37.1%
624,733
-0.2%
0.00%
-50.0%
Q3 2021$10,126,000
+22.5%
626,182
-1.6%
0.00%0.0%
Q2 2021$8,263,000
-0.5%
636,144
+47.9%
0.00%0.0%
Q1 2021$8,304,000430,2270.00%
Other shareholders
VINCERX PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,703,413$1,720,4470.48%
Tejara Capital Ltd 233,348$235,6810.13%
KINGDON CAPITAL MANAGEMENT, L.L.C. 385,000$388,8500.04%
SABBY MANAGEMENT, LLC 57,353$57,9270.04%
Long Focus Capital Management, LLC 1,098,753$1,109,7410.04%
Sio Capital Management, LLC 102,049$103,0690.03%
Rock Springs Capital Management LP 891,719$900,6360.02%
Rubric Capital Management LP 354,377$357,9210.01%
Clearline Capital LP 98,916$99,9050.01%
ExodusPoint Capital Management, LP 389,512$3930.00%
View complete list of VINCERX PHARMA INC shareholders